Big Talks on Big Impacts
To mark World Haemophilia Day, we sit down with Professor Amit Nathwani of the UCL Cancer Institute to explore his journey to commercialising the groundbreaking haemophilia A treatment, Roctavian.
This episode we explore Positive Impact. UCLB is helping to create a new generation of businesses from UCL academics specifically with positive societal impact at their heart.
In this episode, Katy Bruce, CFO of UCL Business, and Charu Gorasia, CFO of UCL, will discuss the mutually beneficial relationship between the technology transfer office, such as UCLB, and the university. They will dive into the research income financial cycle and how the commercialisation income is distributed back into the research ecosystem. This podcast will also cover the challenges around commercialisation income, how to tackle these and what does the future hold.
In the tenth episode, Dr Anne Lane, CEO of UCLB and Dr Chris Hollowood, CEO of Syncona Investment Management, discussed the collaboration between their respective organisations in commercialising research.
In the ninth episode of this podcast series, Ana Lemmo Charnalia, Senior Business Manager at UCLB, is in conversation with Orla O’Donnell , Divisional Manager at the UCL Div of Biosciences and former Chief Operating Officer of HeLP Digital CIC, a Community Interest Company incorporated in 2015 to commercialise HeLP-Diabetes. It is also an opportunity to celebrate Professor Elizabeth Murray’s life, who led in the development of HeLP-Diabetes. Join them in this discussion about their experiences and learnings from an early-stage social venture to the national roll-out of an online programme for people with type 2 diabetes.
Over a 15 year journey, UCLB spinout company Senceive Ltd became the world leader in the design, manufacture and supply of wireless enabled remote condition monitoring solutions for use in rail and construction applications. Recognition of the innovative and scalable nature of Senceive’s solutions to keep people and critical infrastructure safe, led to the company being acquired by Eddyfi in April 2021. In this podcast, Senceive’s now retired CEO Graham Smith and Dr Steven Schooling from UCLB discuss their experiences and learnings as they turned an early-stage university spinout into a highly successful and profitable commercial enterprise, which at exit generated strong returns for all shareholders.
In the seventh episode of this podcast series, Jessica Bolton-Murray, Head of Project Management at UCLB, is in conversation with Tanel Ozdemir, Investment Manager for the UCL Technology Fund.
In the sixth episode of this podcast series, UCLB’s Director of BioPharm, Dr Richard Fagan, is in conversation with Dr Chris Williams. Dr Williams is formerly a Senior Business Manager at UCLB; he is now the SVP, Corporate Development at Autolus. Chris was part of the team that founded Autolus in 2014. Autolus, as a company, is focused on the development of engineered CAR T cell therapies, which has been transformational for patients, particularly in blood cancers.
UCLB CEO Dr Anne Lane appeared on the AUTM On The Air podcast to share her thoughts on the power of collaboration between universities, private, and public organisations, and how TenU (which she previously chaired) has helped foster international collaboration and innovation.
In the fifth episode of this podcast series, Marina Santilli, UCLB Associate Director, Engineering & Physical Sciences is in conversation with Dr. Daniel Hulme, CEO and Founder of Satalia. Satalia was UCL’s very first AI spinout company which is now part of the WPP Group of global companies.